Harrison expands AI leadership with CT Chest launch, now powering nearly half of radiology imaging
New CE-marked CT Chest solution delivers one of the broadest thoracic coverages in the market to help detect critical and chronic conditions.
Sydney, 13 November 2025: Leading health-tech provider, Harrison.ai today announced the launch of its CE-marked CT Chest solution, a comprehensive AI tool that assists clinicians in detecting 167 radiological features, including those that may be suggestive of life-threatening conditions, tumors, and chronic diseases.
With one of the broadest coverages in chest imaging, the Harrison.ai CT Chest identifies close to 9 critical findings such as pulmonary embolism, acute aortic syndrome, pneumothorax, and acute rib fractures. The algorithm priotitises cases on the worklist, intelligently identifies the slices with the findings, localises them with overlays, and provides an interpretation with confidence scores to help clinicians get to the time-sensitive cases faster and interpret with confidence.
The solution acts as a safety net, designed to reduce the risk of missed or underdiagnosed conditions, particularly in emergency and inpatient settings where chronic diseases are often overlooked.
Harrison.ai CT Chest also helps with cancer screening. With up to 70% of lung cancers still diagnosed at later stages1, the solution supports earlier identification of suspected tumors and lesions across lung tissue, soft tissue, mediastinum, lymph nodes, and upper abdomen. Harrison’s Chest CT solution supports radiologists by detecting, staging, and monitoring of features suggestive of lung, gastric, and pancreatic cancers. Harrison.ai CT Chest also helps streamline lung screen workflows through reporting features, designed to save radiologist’s time.
By consolidating functionality typically delivered by multiple point solutions into a single solution, Harrison.ai CT Chest delivers a complete clinical picture.
“After the successful market penetration of our chest X-ray AI solution, expanding into CT chest was a natural next step,” said Dr. Aengus Tran, co-founder and CEO of Harrison.ai. “We’ve seen firsthand how a comprehensive AI solution for a single modality can transform radiology workflows. With CT Chest, we’ve taken the same comprehensive approach to empower clinicians with deeper insights and faster, more confident decision-making.”
Harrison.ai CT Chest empowers both public and private healthcare providers to do more with one solution. It is designed to reduce costs, improve operational efficiency and quality of care for every patient.
For more information, visit Harrison.ai
This product is intended for healthcare professionals only. Some features are not available in all regions, please check regulatory status with a Harrison.ai employee. Harrison.ai CT Chest is the marketing name for HAI-RadX Suite CT Chest.
Headline Data on file
- Radiologist Sensitivity for Lung Nodule Detection: A Meta-Analysis Brown et al. Lung Cancer, 2018, DOI:10.1016/j.lungcan.2018.03.004
About Harrison.ai
Harrison.ai is a global healthcare technology company on a mission to urgently scale healthcare capacity through AI-powered medical imaging diagnostic support and workflow solutions. Its radiology (Annalise.ai) and pathology (Franklin.ai) solutions help clinicians deliver faster, more accurate diagnoses, aiding in the early detection of cancer and other medical conditions. Harrison.ai partners with hospitals and private clinics across APAC, EMEA, the United Kingdom and United States. For more information, visit Harrison.ai.

